Tobacco News and Research

RSS

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose. Opioids are a class of drugs that include prescription medications such as oxycodone, hydrocodone, and morphine, as well as the illegal drug heroin.

18 Nov 2015

Exercise, healthy lifestyle habits may cut prostate cancer risk by up to 68%

A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.

18 Nov 2015

New analysis points to use of e-cigarettes as quitting aid among U.S. adults

Adding to a growing body of research on patterns of e-cigarette use, researchers from Rutgers School of Public Health and the Steven A. Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative have found evidence that among U.S. adults, some recent cigarette quitters may have done so with the assistance of electronic cigarettes.

17 Nov 2015

Tobacco use continues to be a top threat to health and economic well-being of people in China

Efforts over the past seven years to reduce tobacco use in China have been strikingly ineffective and leave tobacco use a top threat to the health and economic well-being of the world's largest country, according to research findings by the University of Waterloo's International Tobacco Control Policy Evaluation Project (ITC Project).

17 Nov 2015

FDA grants accelerated approval for Darzalex to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for treating multiple myeloma.

17 Nov 2015

New cancer control interventions may decrease cancer burden in low- and middle-income countries

In low-income and middle-income countries (LMICs), where 5.5 million of the world’s 8 million cancer deaths occur each year, most people with cancer have little or no access to treatment and many die in severe pain for lack of inexpensive opioid pain medicine.

17 Nov 2015

FDA finalizes innovative food safety rules to prevent foodborne illness

The U.S. Food and Drug Administration today took major steps to prevent foodborne illness by finalizing rules implementing the bipartisan Food Safety Modernization Act that, for the first time, establish enforceable safety standards for produce farms and make importers accountable for verifying that imported food meets U.S. safety standards.

15 Nov 2015

Adynovate approved for patients with Hemophilia A

The U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. Adynovate is modified to last longer in the blood and potentially require less frequent injections than unmodified Antihemophilic Factor when used to reduce the frequency of bleeding.

15 Nov 2015

FDA grants accelerated approval for Tagrisso to treat patients with advanced NSCLC

Today, the U.S. Food and Drug Administration granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung cancer (NSCLC). Tagrisso (osimertinib) is now approved for patients whose tumors have a specific epidermal growth factor receptor (EGFR) mutation (T790M) and whose disease has gotten worse after treatment with other EGFR-blocking therapy.

14 Nov 2015

EU-funded research project aims to reduce oxidation in processed meat products

An EU-funded research project is to make sausages, patties and other meat products healthier in the future. Researchers at Lund University in Sweden, the Swedish University of Agricultural Sciences (SLU) and four other European research institutions have launched a joint project to reduce the risk of colon cancer - the most common cancer of the gastrointestinal tract in Sweden.

13 Nov 2015

Sausages With Antioxidants From Berries To Prevent Cancer

An EU-funded research project is to make sausages, patties and other meat products healthier in the future.

11 Nov 2015

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).

10 Nov 2015

Group therapy helps improve healthy behavior in people with cardiovascular risk factors

Peer group support, in the form of group therapy, was found to help improve healthy behavior in people with cardiovascular risk factors, according to a study released today by Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital. Mount Sinai Heart is ranked No. 7 in the nation by U.S. News & World Report in its 2015 "Best Hospitals" issue.

10 Nov 2015

Major US healthcare database has missing pieces

A major source of American health information data contains a handful of glaring flaws related to health risks, say Johns Hopkins researchers in a study published online Wednesday in the journal PLOS ONE.

9 Nov 2015

Genvoya approved as complete regimen for HIV treatment

The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.

6 Nov 2015

Scientists propose new framework to assess innovative nicotine and tobacco products

Scientists at British American Tobacco have proposed a new scientific framework that could be used to assess the reduced-risk promise of the myriad of innovative nicotine and tobacco products currently being developed.

6 Nov 2015

Nucala (mepolizumab) approved for treatment of asthma patients

The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.

5 Nov 2015

Tobacco cessation program needs to be more widely used for teens with substance abuse issues: Study

Substance abuse treatments that target main issues such as serious drug and alcohol addiction are not frequently being used to also wean adolescents from tobacco, a University of Georgia study finds.

4 Nov 2015

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

The study showed that about thirty percent to maybe half of the leading causes of death in the world are preventable. These are risk factors that you could manage and thus you could prevent a lot of premature deaths.

3 Nov 2015

Sun Valley Juice ordered by FDA to cease all operations

The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.

31 Oct 2015

Tobacco News and Research

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

Exercise, healthy lifestyle habits may cut prostate cancer risk by up to 68%

New analysis points to use of e-cigarettes as quitting aid among U.S. adults

Tobacco use continues to be a top threat to health and economic well-being of people in China

FDA grants accelerated approval for Darzalex to treat patients with multiple myeloma

New cancer control interventions may decrease cancer burden in low- and middle-income countries

FDA finalizes innovative food safety rules to prevent foodborne illness

Adynovate approved for patients with Hemophilia A

FDA grants accelerated approval for Tagrisso to treat patients with advanced NSCLC

EU-funded research project aims to reduce oxidation in processed meat products

Sausages With Antioxidants From Berries To Prevent Cancer

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

Group therapy helps improve healthy behavior in people with cardiovascular risk factors

Major US healthcare database has missing pieces

Genvoya approved as complete regimen for HIV treatment

Scientists propose new framework to assess innovative nicotine and tobacco products

Nucala (mepolizumab) approved for treatment of asthma patients

Tobacco cessation program needs to be more widely used for teens with substance abuse issues: Study

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

Sun Valley Juice ordered by FDA to cease all operations

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News